| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb763467dc2363ea3005a762f5f2612e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc2b03342511abc88f60c63f2acd96d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c403354d21a8bb701ac44f85ef40f3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f4e46557b554f03847407021b168cd87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_415c37bc5f3e8cc6f1f93ea0716609e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13d45af581033b45c173d3c1a2b0e559 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4721 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 |
| filingDate |
2005-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e97ada334823c30f055a8cbeb30a2fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_169a9d86fa3d0a310d76104536e2fac3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_612a02f189418a25abbd0ffc0d21f7c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13bb11ff7eeef03b9cb00a7ecd85f9f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcdab57cc767b71b26cbdedcf4bd69fd |
| publicationDate |
2006-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006017578-A2 |
| titleOfInvention |
Peptide sequence for modulation of delta protein kinase c |
| abstract |
A peptide identified from the annexin V protein sequence and having the ability to modulate the activity of delta protein kinase C (PKC) is described. The peptide and variants thereof bind to delta PKC and are effective to regulate delta PKC mediated cellular responses. In particular the annexin V peptide is able to inhibit protein-protein interaction with delta PKC, blocking intracellular translocation of delta PKC. Inhibition of delta PKC translocation confers protection to tissue at risk of exposure to ischemia or hypoxia or to reperfusion injury. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011506590-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9649355-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008005487-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010505841-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9078913-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016147905-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9682122-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018111717-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2942060-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021098725-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9598677-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8809497-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008005487-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10077438-B2 |
| priorityDate |
2004-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |